Global aging is reshaping healthcare demand. Discover how AbbVie, Amgen, Boston Scientific and Edwards are positioned to gain from this…
Boston Scientific (BSX) ist für mich aus mehreren Gründen eine spannende Option, um den wachsenden Medizintechnikmarkt zu spielen. Beim Investorentag…
The consensus price target hints at a 25.6% upside potential for Boston Scientific (BSX). While empirical research shows that this…
Boston Scientific shares surge as third quarter results top expectations…
Boston Scientific pays $533 million for full ownership of Nalu Medical…
In the most recent trading session, Boston Scientific (BSX) closed at $95.41, indicating a -1.92% shift from the previous trading…
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why…
Here is how Arbutus Biopharma (ABUS) and Boston Scientific (BSX) have performed compared to their sector so far this year.…
Boston Scientific (BSX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it.…
Boston Scientific stock rating downgraded to Hold by Erste Group…
Boston Scientific gains from MedSurg and cardiovascular strength, while Union Pacific and Realty Income face mixed headwinds.…
The latest trading day saw Boston Scientific (BSX) settling at $95.85, representing a -1.82% change from its previous close.…
Boston Scientifics acquisitions and WATCHMAN growth fuel optimism, but currency swings and macro pressures weigh on its outlook.…
23 % Umsatzplus im Q2 – getragen von Erfolgsprodukten wie FARAPULSE und WATCHMAN. Defensives MedTech-Investment – Innovationsführer mit stabiler…
^* Buchanan ist ehemaliger CFO und COO von Silk Road Medical, wo er erfolgreich ein Medizintechnikunternehmen in…
Boston Scientific stock falls after FDA discloses defibrillation lead issue…
Key PointsRevenue climbed to $5.06 billion in Q2 2025, up 23% from the prior year period and 3.4% above analyst…
David Keller breaks down the charts in Boston Scientific.…
Boston Scientific (BSX) delivered earnings and revenue surprises of +4.17% and +3.48%, respectively, for the quarter ended June 2025. Do…
BSX beats Q2 estimates, raises full-year outlook as Cardiovascular sales surge and global revenues climb 22.8%.…
Boston Scientific (BSX) reached $104.33 at the closing of the latest trading day, reflecting a +1.09% change compared to its…
In the most recent trading session, Boston Scientific (BSX) closed at $102.41, indicating a -1.37% shift from the previous trading…
Boston Scientific stock rises as TD Cowen reiterates Buy rating…
Boston Scientific (BSX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients…
BSX rallies 40.5% in a year, fueled by WATCHMAN growth, MedSurg gains, acquisitions and global expansion efforts.…
Boston Scientific (BSX) reached $106.53 at the closing of the latest trading day, reflecting a +1.86% change compared to its…
As MedSurg demand rises, Boston Scientific and Medtronic compete for dominance. Which stock shows stronger growth momentum now?…
Here is how Ensign Group (ENSG) and Boston Scientific (BSX) have performed compared to their sector so far this year.…
According to the average brokerage recommendation (ABR), one should invest in Boston Scientific (BSX). It is debatable whether this highly…